| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b5afde90a4d82db0c25bd66504c3eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_871cd1e79d03079c11faed63582d4e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60c5c76b9cc9b56882982b33fcc3f4f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_540eec52930b35c22108814088f97cb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f768578ea1274952c85eb6a51d80a183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b4e27935e95e738e0d786149fbaa9d6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58 |
| filingDate |
2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e994d2ddb06914e1cb06bdc3066a9be5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53c20d889239cb32650dc1764d008249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22d32dfa68df59b61522e27f5a67fe63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f02135d8c4ebd3199a2df19db9d836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31504c5202f8232bfe07bef8843ad468 |
| publicationDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-RE44613-E |
| titleOfInvention |
N-substituted glycine derivatives: hydroxylase inhibitors |
| abstract |
The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I) n nwhich are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10694739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9986733-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510407-B2 |
| priorityDate |
2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |